MedPath

Effect of Yoga on Non-alcoholic fatty Liver

Not Applicable
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2020/11/029262
Lead Sponsor
Rakhi Mishra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age between 25 to 50 years.

Liver steatosis grade II & III diagnosed with Fibroscan (Fibrosis score F2 and F3; 7.5 to 10 kPa and 10-14 kPa respectively and Steatosis grade higher than 290 dB/m) [Memorial Sloan Kettering cancer center]

BMI

Overweight - 25-29.9

Obese - >= 30

Obese Type-I - 30-40

Obese Type-II - 40.1- 50

Obese Type III - >50

Medically Diagnosed with Hypertension

Exclusion Criteria

Enrolled under any other lifestyle modification program like gym, meditation

Diagnosed with neurological, cardiovascular or orthopedic issues.

Diagnosed with liver disease of other etiology.

Practicing Regular Yoga

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anthropometric measurement: <br/ ><br>BMI, Waist circumference, Waist/Hip Ratio <br/ ><br>Surrogate Biomarkers: <br/ ><br>AST, ALT, GGT <br/ ><br>Lipid profile <br/ ><br>Triglycerides HDL-cholesterol <br/ ><br>Leptin <br/ ><br>C-reactive Protein <br/ ><br>Fasting glucose <br/ ><br>Albumin <br/ ><br>Platelets <br/ ><br>Steatosis Grade:Fibrosis score <br/ ><br>CAP score <br/ ><br>Timepoint: Pre-Interventional <br/ ><br>Baseline assessment <br/ ><br>Day 1 <br/ ><br>Post Interventional assessment- <br/ ><br>First- 12th week <br/ ><br>Second-24th week <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To develop standardized protocol for non-alcoholic fatty liver disease <br/ ><br>Timepoint: 24th week
© Copyright 2025. All Rights Reserved by MedPath